These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 30926526)
1. Alginate lyase immobilized chitosan nanoparticles of ciprofloxacin for the improved antimicrobial activity against the biofilm associated mucoid P. aeruginosa infection in cystic fibrosis. Patel KK; Tripathi M; Pandey N; Agrawal AK; Gade S; Anjum MM; Tilak R; Singh S Int J Pharm; 2019 May; 563():30-42. PubMed ID: 30926526 [TBL] [Abstract][Full Text] [Related]
2. Enhancing the Thermo-Stability and Anti-Biofilm Activity of Alginate Lyase by Immobilization on Low Molecular Weight Chitosan Nanoparticles. Li S; Wang Y; Li X; Lee BS; Jung S; Lee MS Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540110 [TBL] [Abstract][Full Text] [Related]
3. Enzyme-Linked Lipid Nanocarriers for Coping Pseudomonal Pulmonary Infection. Would Nanocarriers Complement Biofilm Disruption or Pave Its Road? Nafee N; Gaber DM; Abouelfetouh A; Alseqely M; Empting M; Schneider M Int J Nanomedicine; 2024; 19():3861-3890. PubMed ID: 38708178 [TBL] [Abstract][Full Text] [Related]
4. The effect of alginate lyase on the gentamicin resistance of Pseudomonas aeruginosa in mucoid biofilms. Germoni LA; Bremer PJ; Lamont IL J Appl Microbiol; 2016 Jul; 121(1):126-35. PubMed ID: 27061817 [TBL] [Abstract][Full Text] [Related]
5. Disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate lyase enhances pathogen eradication by antibiotics. Daboor SM; Rohde JR; Cheng Z J Cyst Fibros; 2021 Mar; 20(2):264-270. PubMed ID: 32482592 [TBL] [Abstract][Full Text] [Related]
6. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections. Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase). Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442 [TBL] [Abstract][Full Text] [Related]
8. Marine Bacteria, A Source for Alginolytic Enzyme to Disrupt Daboor SM; Raudonis R; Cohen A; Rohde JR; Cheng Z Mar Drugs; 2019 May; 17(5):. PubMed ID: 31137680 [No Abstract] [Full Text] [Related]
10. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance. Sousa AM; Monteiro R; Pereira MO Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031 [TBL] [Abstract][Full Text] [Related]
11. In-vitro evaluation of a ciprofloxacin- and ivacaftor-coated sinus stent against Pseudomonas aeruginosa biofilms. Cho DY; Lim DJ; Mackey C; Weeks CG; Garcia JAP; Skinner D; Zhang S; McCormick J; Woodworth BA Int Forum Allergy Rhinol; 2019 May; 9(5):486-492. PubMed ID: 30702211 [TBL] [Abstract][Full Text] [Related]
13. Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication. Wang J; Guo Y; Lu W; Liu X; Zhang J; Sun J; Chai G Int J Pharm; 2024 Jun; 658():124208. PubMed ID: 38723731 [TBL] [Abstract][Full Text] [Related]
15. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients. Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776 [TBL] [Abstract][Full Text] [Related]
16. Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms. Armijo LM; Wawrzyniec SJ; Kopciuch M; Brandt YI; Rivera AC; Withers NJ; Cook NC; Huber DL; Monson TC; Smyth HDC; Osiński M J Nanobiotechnology; 2020 Feb; 18(1):35. PubMed ID: 32070354 [TBL] [Abstract][Full Text] [Related]
17. Alginate Lyase Guided Silver Nanocomposites for Eradicating Wan B; Zhu Y; Tao J; Zhu F; Chen J; Li L; Zhao J; Wang L; Sun S; Yang Y; Zhang X; Zhang Y ACS Appl Mater Interfaces; 2020 Feb; 12(8):9050-9061. PubMed ID: 32024363 [No Abstract] [Full Text] [Related]
18. Screening, cloning and expression of a novel alginate lyase gene from P. aeruginosa TAG 48 and its antibiofilm effects on P. aeruginosa biofilm. Tavafi H; Ali AA; Ghadam P; Gharavi S Microb Pathog; 2018 Nov; 124():356-364. PubMed ID: 30118807 [TBL] [Abstract][Full Text] [Related]
19. In vitro antibacterial activity of ciprofloxacin loaded chitosan microparticles and their effects on human lung epithelial cells. Kucukoglu V; Uzuner H; Kenar H; Karadenizli A Int J Pharm; 2019 Oct; 569():118578. PubMed ID: 31362096 [TBL] [Abstract][Full Text] [Related]
20. Molecular modeling and redesign of alginate lyase from Pseudomonas aeruginosa for accelerating CRPA biofilm degradation. Cho H; Huang X; Lan Piao Y; Eun Kim D; Yeon Lee S; Jeong Yoon E; Hee Park S; Lee K; Ho Jang C; Zhan CG Proteins; 2016 Dec; 84(12):1875-1887. PubMed ID: 27676452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]